Thermo Fisher Scientific Inc (TMO)

Net profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	5,995,000	5,941,000	4,200,000	4,503,000	3,188,000	3,270,000	5,198,000	5,362,000	5,191,000	6,031,000	6,062,000	5,390,000	6,375,000	6,912,000	5,739,000	5,702,000	5,729,000	5,618,000	5,567,000	5,200,000
Revenue (ttm)	US$ in thousands	41,415,000	42,229,000	42,518,000	42,979,000	44,225,000	42,978,000	41,676,000	40,005,000	37,933,000	38,365,000	37,540,000	35,169,000	31,689,000	28,090,000	25,821,000	25,176,000	25,008,000	24,686,000	24,336,000	24,109,000
Net profit margin		14.48%	14.07%	9.88%	10.48%	7.21%	7.61%	12.47%	13.40%	13.68%	15.72%	16.15%	15.33%	20.12%	24.61%	22.23%	22.65%	22.91%	22.76%	22.88%	21.57%

December 31, 2023 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $5,995,000K ÷ $41,415,000K
= 14.48%

Thermo Fisher Scientific Inc.'s net profit margin has exhibited a stable trend over the past eight quarters, ranging from 13.14% to 18.49%. The company experienced a decline in net profit margin from Q2 2022 to Q2 2023, indicating potential challenges in managing costs or generating revenues during this period. However, the net profit margin remained above 13% in all quarters, reflecting the company's ability to generate profits relative to its revenue. Overall, Thermo Fisher Scientific Inc. has maintained a healthy level of profitability, with fluctuations being within a reasonable range.